UK Hospital Trials 60-Second Test for Winter Respiratory Infections
University Hospital Southampton is trialing a point-of-care biosensor test for flu, COVID-19, and RSV, delivering results in four minutes, according to the hospital.
Read MorePosted by CLP Edit Staff | Jan 27, 2026 | Covid 19, Flu & Respiratory Infections |
University Hospital Southampton is trialing a point-of-care biosensor test for flu, COVID-19, and RSV, delivering results in four minutes, according to the hospital.
Read MorePosted by CLP Edit Staff | Jan 27, 2026 | Cancer |
A real-world study of 111,080 participants found the Galleri multi-cancer blood test achieved a 0.91% cancer detection rate and 87% accuracy in predicting tumor origin.
Read MorePosted by CLP Edit Staff | Jan 26, 2026 | Histology |
Tempus has introduced Paige Predict, an AI-powered pathology suite that analyzes H&E slides to predict 123 biomarkers across 16 cancer types when tissue samples are insufficient.
Read MorePosted by CLP Edit Staff | Jan 23, 2026 | Diabetes & Metabolic Diseases |
HistoIndex and Houston Research Institute have partnered to offer AI-driven pathology analysis for metabolic dysfunction-associated steatohepatitis across four HRI centers in Texas, expanding advanced diagnostic services for liver disease.
Read MorePosted by CLP Edit Staff | Jan 22, 2026 | Quality Control Programs |
bioMérieux has acquired Accellix for about €35 million, adding rapid, automated flow cytometry to its pharmaceutical quality control portfolio for cell and gene therapy manufacturing.
Read More